55% af de imatinib - resistente patienter uden tidligere MCyR med imatinib (n= 288) opnåede MCyR med dasatinib.
Fifty-five percent of the imatinib-resistant patients with no prior MCyR to imatinib (n= 288) achieved a MCyR with dasatinib.